After being rejected twice, Horizon pushes Depomed to accept its €2.7Bn offer
Horizon Pharma is getting anxious and has offered the substantial amount of €2.7Bn to buy its…
13/07/2015 - 1 minute
Neurological disorders
First-in-human successful Phase I for an Alzheimer’s vaccine
AXON Neuroscience has completed a pioneer Phase I that offers new hope for millions of…
10/07/2015 - 2 minutes
Roche and Evotec knocked down by their Alzheimer candidate
The progressive aging of the population in developed countries is turning Alzheimer into one of…
02/07/2015 - 2 minutes
Alkermes presents its new treatment of Alzheimer’s agitation
Alkermes reveals a new drug candidate, ALKS 7119, for treatment of Alzheimer’s agitation, depression and…
04/03/2015 - 2 minutes
#BioFigures: 3,000 whole genomes sequenced to fight Parkinson!
WHO? 23andMe, founded in 2006, is the leading personal genetics company dedicated to helping people…
18/02/2015 - 2 minutes
AB Science: One step further towards a cure to Alzheimer’s disease
AB Science SA, a pharmaceutical company specialized in research, development and marketing of protein kinase…
11/02/2015 - 2 minutes
Stemedica International succeed in a pre-clinical trial to treat Alzheimer’s disease with stem cells
Stemedica International, a Stemedica Cell Technologies Inc. subsidiary developing stem cell therapies for Alzheimer’s disease…
21/08/2014 - 2 minutes
